Skip to main content

Advertisement

Log in

Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to compare the outcomes of surgery and stereotactic body radiotherapy (SBRT) for elderly clinical stage I non-small cell lung cancer (NSCLC) patients.

Methods

Patients ≥80 years of age with clinical stage I NSCLC between August 2008 and December 2014 were treated either surgery or SBRT. Propensity score matching was performed to reduce bias in various clinicopathological factors.

Results

Surgery was performed in 57 cases and SBRT in 41 cases. In the surgery group, the operations included 34 lobectomies and 23 sublobar resections. In the SBRT group, 27 cases were given 48 Gy in 4 fractions, and 14 were given 60 Gy in 10 fractions. Similar characteristics were identified in age (82 years), gender (male:female ratio 2:1), tumor size (2.2 cm), carcinoembryonic antigen (3.6 ng/ml), Charlson comorbidity index (1), Glasgow prognostic scale (0), and forced expiratory volume in 1 s (1.7 L) after matching. Before matching, the 5-year overall survival (OS) in surgery (68.3%) was significantly better than that in SBRT (47.4%, p = 0.02), and the 5-year disease-specific survival (DSS) (94.1%, 78.2%, p = 0.17) was not significantly different between the groups. The difference in the 5-year OS became non-significant between the matched pairs (57.0%, 49.1%, p = 0.56).

Conclusions

The outcomes of surgery and SBRT for elderly patients with the early stage NSCLC were roughly the same.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ministry of Health, Labour and Welfare of Japan. Abridged life tables for Japan 2013. Tokyo: Government of Japan; 2013. http://www.mhlw.go.jp/toukei/saikin/hw/life/life13/. Accessed 1 Oct 2016.

  2. Guerra M, Neves P, Miranda J. Surgical treatment of non-small-cell lung cancer in octogenarians. Interact Cardiovasc Thorac Surg. 2013;16:673–80.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Okami J, Higashiyama M, Asamura H, Goya T, Koshiishi Y, Sohara Y, et al. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small-cell lung cancer. Prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol. 2009;4:1247–53.

    Article  PubMed  Google Scholar 

  4. Umezu H, Miyoshi S, Araki O, Karube Y, Tamura M, Kobayashi S, et al. Efficacy of functional operability algorithm for octogenarians with primary lung cancer. Gen Thorac Cardiovasc Surg. 2012;60:36–42.

    Article  PubMed  Google Scholar 

  5. Endo H, Yamamoto R, Satoh Y, Kuwano H, Nishizawa N. Risk analysis of pulmonary resection for elderly patients with lung cancer. Surg Today. 2013;43:514–20.

    Article  Google Scholar 

  6. Okada A, Hirono T, Watanabe T. Safety and prognosis of limited surgery for octogenarians with non-small-cell lung cancer. Gen Thorac Cardiovasc Surg. 2012;60:97–103.

    Article  PubMed  Google Scholar 

  7. Eba J, Nakamura K, Mizusawa J, Suzuki K, Nagata Y, Koike T, et al. Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A). Jpn J Clin Oncol. 2016;46:748–53.

    Article  PubMed  Google Scholar 

  8. Mun M, Kohno T. Video-assisted thoracic surgery for clinical stage I lung cancer in octogenarians. Ann Thorac Surg. 2008;85:406–11.

    Article  PubMed  Google Scholar 

  9. Saji H, Ueno T, Nakamura H. Prospective observational cohort study of postoperative risk and prognosis scoring for elderly patients with medically operable lung cancer (JACS1303). Gen Thorac Cardiovasc Surg. 2016;64:634–5.

    Article  PubMed  Google Scholar 

  10. Mokhles S, Verstegen N, Maat A, Birim Ö, Bogers A, Mohkles MM, et al. Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: results from propensity score analysis. Lung Cancer. 2015;87:283–9.

    Article  PubMed  Google Scholar 

  11. Shirvani SM, Jiang J, Chang JY, Welsh J, Likhacheva A, Buchholzz TA, et al. Lobectomy, sublobar resection, and stereotactic radiation for early-stage non-small cell lung cancers in the elderly. JAMA Surg. 2014;149:1244–53.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Matsuo Y, Chen F, Hamaji M, Kawaguchi A, Ueki N, Nagata Y, et al. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small cell lung cancer in patients at high risk for lobectomy: a propensity score matching analysis. Eur J Cancer. 2014;50:2932–8.

    Article  PubMed  Google Scholar 

  13. Paul S, Lee PC, Mao J, Isaacs AJ, Sedrakyn A. Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis. BMJ. 2016;354:i3570.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Chang JY, Senan S, Paul MA, Mehran RJ, Luie AV, Balter P, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomized trial. Lancet Oncol. 2015;16:630–7.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hamaji M, Chen F, Matsuo Y, Kawaguchi A, Morita S, Ueki N, et al. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer. Ann Thorac Surg. 2015;99:1122–9.

    Article  PubMed  Google Scholar 

  16. Rosen JE, Salazar MC, Wang A, Yu JB, Decker RH, Kin AW, et al. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. J Thorac Cardiovasc Surg. 2016;152:44–54.

    Article  PubMed  Google Scholar 

  17. Chida M, Minowa M, Karube Y, Eba S, Okada Y, Miyoshi S, et al. Worsened long-term outcomes and postoperative complications in octogenarians with lung cancer following mediastinal lymph-node dissection. Interact Cardiovasc Thorac Surg. 2009;8:89–92.

    Article  PubMed  Google Scholar 

  18. Katayama H, Kurokawa Y, Nakamura K, Itoh H, Kanemitsu Masuda N, et al. Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46:668–85.

    Article  PubMed  Google Scholar 

  19. Kanzaki R, Inoue M, Minami M, Shintani Y, Funaki S, Kawamura T, et al. Outcomes of lung cancer surgery in patients with coronary artery disease: a decade of experience at a single institution. Surg Today. 2017;47:27–34.

    Article  PubMed  Google Scholar 

  20. Shiga, M, Maeda, H, Oba, K, Okamoto K, Namikawa T, Fujisawa K, et al. Safety of laparoscopic surgery for colorectal cancer in patients over 80 years old: a propensity score matching study. Surg Today. 2017. (epub ahead of print).

  21. Miyazaki T, Sakai T, Tsuchiya T, Yamasaki N, Tagawa T, Mine M, et al. Assessment and follow-up of intercostal nerve damage after video-assisted thoracic surgery. Eur J Cardiothorac Surg. 2011;39:1033–9.

    Article  PubMed  Google Scholar 

  22. Muraoka M, Oka T, Akamine S, Tagawa T, Sasaki N, Ikuta Y, et al. Surgical treatment for lung cancer in octogenarians. Surg Today. 2005;35:725–31.

    Article  PubMed  Google Scholar 

  23. Solda F, Lodge M, Ashley S, Whitington A, Goldstraw P, Brada M. Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. Radiother Oncol. 2013;109:1–7.

    Article  PubMed  Google Scholar 

  24. Takeda A, Sanuki N, Eriguchi T, Kaneko T, Morita S, Handa H, et al. Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013;86:257–63.

    Article  PubMed  Google Scholar 

  25. Nakagawa T, Negoro Y, Matsuoka T, Okumura N, Dodo Y. Comparison of the outcomes of stereotactic body radiotherapy and surgery in elderly patients with cT1-2N0M non-small cell lung cancer. Respir Investig. 2014;52:221–6.

    Article  PubMed  Google Scholar 

  26. Nanda RH, Liu Y, Gillespie TW, Mikell JL, Ramalimgam SS, Fernandez FG, et al. Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: a national cancer data base analysis. Cancer. 2015;23:4222–30.

    Article  Google Scholar 

  27. Jeppesen SS, Schytte T, Jensen HR, Brink C, Hansen O. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates. Acta Oncol. 2013;52:1552–8.

    Article  PubMed  Google Scholar 

  28. Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, et al. Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys. 2015;93:989–96.

    Article  PubMed  Google Scholar 

  29. Takahashi N, Sawabata N, Kawamura M, Ohtsuka T, Horio H, Sakaguchi H, et al. Multicenter prospective study of sublobar resection for c-stage I non-small cell lung cancer patients unable to undergo lobectomy (KLSG-0801): complete republication. Gen Thorac Cardiovasc Surg. 2016;64(8):470–5.

    Article  PubMed  Google Scholar 

  30. Yu JB, Soulos PR, Cramer LD, Decker RH, Kim AW, Gross CP. Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer. Cancer. 2015;121:2341–9.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takuro Miyazaki.

Ethics declarations

Funding

None.

Conflict of interest

The authors declare no competing financial conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miyazaki, T., Yamazaki, T., Nakamura, D. et al. Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis. Surg Today 47, 1476–1483 (2017). https://doi.org/10.1007/s00595-017-1536-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-017-1536-4

Keywords

Navigation